Tscan TherapeuticsTCRX
13F holders, Q2 2024 (June 30)81holders +15
31new positions
16sold out
3famous investors
$5.85avg. 13F price*
At the end of Q2 2024, 81 institutions reported holding Tscan Therapeutics Inc. (TCRX) in their 13F filings, up 15 from Q1 2024. 31 opened new positions and 16 sold out. The largest holders were Lynx1 Capital Management LP ($30.6M), EcoR1 Capital, LLC ($29.3M) and BlackRock Inc. ($26.1M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Tscan Therapeutics Inc.
- CUSIP
- 89854M101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 31 | $23.0M |
| Exits | 16 | $5.1M |
All 13F filers, Q1 2024 → Q2 2024: 9,119,550 shares bought and 1,942,861 shares sold, net +7,176,689 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 81 holders
| Lynx1 Capital Management LP | 11.03% | No change | 5,224,600 | $30.6M |
| EcoR1 Capital, LLC | 0.90% | No change | 5,000,000 | $29.3M |
| BlackRock Inc. | 0.00% | Add +162.6% | 4,462,352 | $26.1M |
| Adage Capital Partners Gp, L.L.C. | 0.05% | Add +12.8% | 4,400,000 | $25.7M |
| BVF Inc. | 0.49% | No change | 2,989,474 | $17.5M |
| Baker Bros. Advisors LP | 0.21% | No change | 2,784,792 | $16.3M |
| Vanguard Group Inc. | 0.00% | Add +18.0% | 2,133,613 | $12.5M |
| Propel Bio Management, LLC | 7.92% | No change | 2,087,139 | $12.2M |
| Deer Management Co. LLC | 1.50% | No change | 1,245,504 | $7.3M |
| Alphabet Inc. | 0.32% | No change | 1,077,080 | $6.3M |
| Simplify Asset Management Inc. | 0.54% | No change | 1,046,916 | $6.1M |
| Great Point Partners LLC | 1.05% | New | 940,831 | $5.5M |
| Geode Capital Management, LLC | 0.00% | Add +117.6% | 900,499 | $5.3M |
| Stempoint Capital LP | 1.45% | New | 845,069 | $4.9M |
| LMR Partners LLP | 0.11% | New | 665,529 | $3.9M |
| DC Funds, LP | 61.20% | No change | 630,000 | $3.7M |
| State Street Corp. | 0.00% | Add +350.4% | 608,085 | $3.6M |
| Invesco Ltd. | 0.00% | Add +2.4% | 499,874 | $2.9M |
| Paradigm Biocapital Advisors LP | 0.08% | New | 353,886 | $2.1M |
| Marshall Wace, LLP | 0.00% | Add +60.8% | 307,487 | $1.8M |
| Aberdeen Group plc | 0.00% | Add +46.1% | 292,144 | $1.7M |
| Morgan Stanley | 0.00% | Add +7.9% | 241,672 | $1.4M |
| Tocqueville Asset Management L.P. | 0.02% | Reduce -1.1% | 209,830 | $1.2M |
| Woodline Partners LP | 0.01% | New | 163,492 | $956K |
| Citadel Advisors | 0.00% | Add +1281.8% | 157,963 | $924K |
| Alpine Global Management, LLC | 0.15% | New | 137,490 | $804K |
| Bank of Montreal | 0.00% | New | 120,454 | $749K |
| Bank of New York Mellon Corp | 0.00% | New | 116,658 | $682K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +410.9% | 112,941 | $661K |
| Walleye Capital LLC | 0.01% | Add +105.2% | 107,665 | $630K |
| Jane Street Group, LLC | 0.00% | Reduce -35.3% | 99,036 | $579K |
| Northern Trust Corp. | 0.00% | Add +26.7% | 97,512 | $570K |
| Stifel Financial Corp. | 0.00% | Reduce -5.9% | 95,400 | $558K |
| Troluce Capital Advisors LLC | 0.11% | New | 92,832 | $543K |
| NewEdge Wealth, LLC | 0.01% | No change | 91,463 | $535K |
| Wellington Management Group LLP | 0.00% | New | 90,941 | $532K |
| Renaissance Technologies | 0.00% | Add +70.2% | 80,000 | $468K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -45.4% | 78,385 | $459K |
| Brown Brothers Harriman & Co. | 0.00% | New | 76,024 | $445K |
| Nuveen Asset Management, LLC | 0.00% | New | 69,962 | $409K |
| Laurion Capital Management LP | 0.01% | Reduce -83.3% | 60,400 | $353K |
| American Century Companies Inc. | 0.00% | Add +48.9% | 47,481 | $278K |
| Rhumbline Advisers | 0.00% | New | 46,867 | $274K |
| Bank of America Corp. | 0.00% | Add +45.1% | 43,782 | $256K |
| Bridgeway Capital Management, LLC | 0.01% | Reduce -39.5% | 38,300 | $224K |
| DC Investments Management, LLC | 0.18% | No change | 35,563 | $208K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -86.4% | 35,268 | $206K |
| Millennium Management | 0.00% | Reduce -92.9% | 27,889 | $163K |
| Cornercap Investment Counsel Inc. | 0.02% | New | 22,940 | $134K |
| EntryPoint Capital, LLC | 0.06% | New | 21,899 | $128K |
| Pale Fire Capital SE | 0.01% | No change | 21,573 | $126K |
| Letko, Brosseau & Associates Inc. | 0.00% | No change | 20,700 | $121K |
| Corebridge Financial, Inc. | 0.00% | — | 20,658 | $121K |
| Deutsche Bank AG | 0.00% | New | 20,638 | $121K |
| New York State Common Retirement Fund | 0.00% | New | 20,093 | $118K |
| Squarepoint Ops LLC | 0.00% | New | 19,290 | $113K |
| Man Group plc | 0.00% | Reduce -75.9% | 18,651 | $109K |
| JPMorgan Chase & Co. | 0.00% | Reduce -75.6% | 16,364 | $96K |
| Manufacturers Life Insurance Company, The | 0.00% | New | 15,383 | $90K |
| Wells Fargo & Company | 0.00% | Add +4437.9% | 13,886 | $81K |
| Voya Investment Management LLC | 0.00% | New | 13,603 | $80K |
| Marathon Trading Investment Management LLC | 0.02% | Reduce -73.3% | 13,600 | $80K |
| Barclays PLC | 0.00% | New | 13,164 | $77K |
| UBS Group AG | 0.00% | Add +565.2% | 12,645 | $74K |
| Osaic Holdings, Inc. | 0.00% | New | 12,245 | $72K |
| Dimensional Fund Advisors LP | 0.00% | New | 11,882 | $70K |
| Privium Fund Management (UK) Ltd | 0.03% | Reduce -23.5% | 12,103 | $69K |
| Jump Financial, LLC | 0.00% | Add +4.9% | 10,792 | $63K |
| MetLife Investment Management, LLC | 0.00% | New | 10,199 | $60K |
| Aries Wealth Management | 0.02% | No change | 10,000 | $59K |
| Waldron Private Wealth LLC | 0.00% | No change | 10,000 | $59K |
| Citigroup Inc. | 0.00% | Reduce -92.8% | 8,446 | $49K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 4,224 | $25K |
| Legal & General Group Plc | 0.00% | New | 3,937 | $23K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 3,762 | $22K |
| Royal Bank of Canada | 0.00% | New | 3,611 | $21K |
| California State Teachers Retirement System | 0.00% | New | 2,782 | $16K |
| Amalgamated Bank | 0.00% | New | 1,329 | $8K |
| Atlas Capital Advisors Inc. | 0.00% | No change | 18 | $105 |
| T. Rowe Price Associates Inc. | 0.00% | New | 12,301 | $0 |
| Lazard Asset Management LLC | 0.00% | Reduce -93.1% | 176 | $0 |
"% of holder's portfolio" is TCRX's weight in each manager's 13F, not the share of Tscan Therapeutics Inc. the manager owns.